Audit 6673

FY End
2023-09-30
Total Expended
$1.61B
Findings
0
Programs
211
Year: 2023 Accepted: 2023-12-14

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $134.46M - 0
84.268 Federal Direct Student Loans $39.97M Yes 0
10.557 Wic Special Supplemental Nutrition Program for Women, Infants, and Children $4.86M - 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $4.48M Yes 0
93.351 Research Infrastructure Programs $3.31M Yes 0
93.859 Biomedical Research and Research Training $1.96M Yes 0
93.839 Blood Diseases and Resources Research $1.81M Yes 0
93.867 Vision Research $1.78M Yes 0
93.173 Research Related to Deafness and Communication Disorders $1.69M Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $1.66M Yes 0
93.838 Covid-19 Lung Diseases Research $1.53M Yes 0
93.242 Covid-19 Mental Health Research Grants $1.38M Yes 0
93.940 Hiv Prevention Activities Health Department Based $1.34M - 0
93.084 Covid-19 Prevention of Disease, Disability, and Death by Infectious Diseases $1.24M Yes 0
93.233 National Center on Sleep Disorders Research $1.22M Yes 0
93.273 Alcohol Research Programs $1.20M Yes 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $1.18M - 0
93.172 Human Genome Research $1.15M Yes 0
93.788 Opioid Str $1.03M - 0
93.350 National Center for Advancing Translational Sciences $946,921 Yes 0
93.RD Federal Aviation Administration Contracts $923,977 Yes 0
47.076 Stem Education (formerly Education and Human Resources) $843,224 Yes 0
93.395 Covid-19 Cancer Treatment Research $811,725 Yes 0
93.213 Research and Training in Complementary and Integrative Health $721,192 Yes 0
12.351 Scientific Research - Combating Weapons of Mass Destruction $701,673 Yes 0
93.279 Covid-19 Drug Abuse and Addiction Research Programs $623,521 Yes 0
93.349 Packaging and Spreading Proven Pediatric Weight Management Interventions for Use by Low-Income Families $571,623 Yes 0
93.326 Strengthening Public Health Through Surveillance, Epidemiologic Research, Disease Detection and Prevention $568,571 Yes 0
12.750 Covid-19 Uniformed Services University Medical Research Projects $560,916 Yes 0
93.326 Covid-19 Strengthening Public Health Through Surveillance, Epidemiologic Research, Disease Detection and Prevention $530,123 Yes 0
93.121 Oral Diseases and Disorders Research $497,758 Yes 0
93.917 Hiv Care Formula Grants $429,456 - 0
93.318 Covid-19 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $427,775 - 0
93.307 Minority Health and Health Disparities Research $406,537 Yes 0
93.393 Cancer Cause and Prevention Research $394,797 Yes 0
93.855 Covid-19 Allergy and Infectious Diseases Research $381,971 Yes 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $366,785 Yes 0
93.914 Hiv Emergency Relief Project Grants $342,896 - 0
93.732 Covid-19 Mental and Behavioral Health Education and Training Grants $330,904 Yes 0
93.393 Covid-19 Cancer Cause and Prevention Research $325,243 Yes 0
14.241 Housing Opportunities for Persons with Aids $292,841 - 0
12.300 Basic, Applied, and Advanced Research in Science and Engineering $286,612 Yes 0
16.842 Opioid Affected Youth Initiative $281,867 Yes 0
93.396 Cancer Biology Research $274,192 Yes 0
93.738 Covid-19 Pphf: Racial and Ethnic Approaches to Community Health Program Financed Solely by Public Prevention and Health Funds $266,515 Yes 0
81.135 Advanced Research Projects Agency - Energy $248,265 Yes 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $241,966 - 0
84.425 Covid-19 Education Stabilization Fund $227,269 - 0
93.226 Research on Healthcare Costs, Quality and Outcomes $226,623 Yes 0
93.RD U.s. Department of Transportation Contracts $211,581 Yes 0
93.397 Covid-19 Cancer Centers Support Grants $206,512 Yes 0
93.RD Covid-19 Centers for Diseases Control and Prevention Contracts $205,673 Yes 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $204,492 Yes 0
93.211 Telehealth Programs $193,510 - 0
93.870 Maternal, Infant and Early Childhood Home Visiting Grant $192,897 - 0
93.738 Pphf: Racial and Ethnic Approaches to Community Health Program Financed Solely by Public Prevention and Health Funds $187,383 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $184,655 Yes 0
12.800 Air Force Defense Research Sciences Program $183,630 Yes 0
93.U02 Substance Abuse and Mental Health Services Administration $182,887 - 0
93.262 Occupational Safety and Health Program $179,772 Yes 0
93.RD Federal Communications Commission Contracts $168,686 Yes 0
93.825 National Ebola Training and Education Center (netec) $157,053 Yes 0
12.420 Military Medical Research and Development $157,014 Yes 0
47.041 Engineering $156,867 Yes 0
20.614 National Highway Traffic Safety Administration (nhtsa) Discretionary Safety Grants and Cooperative Agreements $155,438 - 0
93.310 Covid-19 Trans-Nih Research Support $154,923 Yes 0
93.853 Covid-19 Extramural Research Programs in the Neurosciences and Neurological Disorders $147,187 Yes 0
93.495 Covid-19 Community Health Workers for Public Health Response and Resilient $138,830 - 0
93.276 Drug-Free Communities Support Program Grants $138,223 - 0
11.609 Measurement and Engineering Research and Standards $137,841 Yes 0
93.113 Covid-19 Environmental Health $137,093 Yes 0
93.865 Covid-19 Child Health and Human Development Extramural Research $136,669 Yes 0
93.268 Covid-19 Immunization Cooperative Agreements $134,849 - 0
93.397 Cancer Centers Support Grants $130,725 Yes 0
93.837 Covid-19 Cardiovascular Diseases Research $128,753 Yes 0
93.310 Trans-Nih Research Support $125,905 Yes 0
11.307 Economic Adjustment Assistance $122,418 - 0
93.RD Biomedical Advanced Research and Development Authority $122,161 Yes 0
93.266 Health Systems Strengthening and Hiv/aids Prevention, Care and Treatment Under the President's Emergency Plan for Aids Relief $119,751 - 0
93.604 Assistance for Torture Victims $116,967 Yes 0
98.006 Foreign Assistance to American Schools and Hospitals Abroad (asha) $114,698 - 0
93.394 Cancer Detection and Diagnosis Research $112,114 Yes 0
93.817 Hospital Preparedness Program (hpp) Ebola Preparedness and Response Activities $110,522 - 0
12.910 Research and Technology Development $110,242 Yes 0
98.001 Usaid Foreign Assistance for Programs Overseas $109,170 - 0
47.075 Social, Behavioral, and Economic Sciences $108,656 Yes 0
93.846 Covid-19 Arthritis, Musculoskeletal and Skin Diseases Research $107,973 Yes 0
12.630 Basic, Applied, and Advanced Research in Science and Engineering $107,479 Yes 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $105,363 Yes 0
93.879 Covid-19 Medical Library Assistance $95,749 Yes 0
93.153 Coordinated Services and Access to Research for Women, Infants, Children, and Youth $95,719 - 0
93.958 Block Grants for Community Mental Health Services $93,538 Yes 0
93.184 Disabilities Prevention $93,510 - 0
10.569 Emergency Food Assistance Program (food Commodities) $92,256 - 0
19.345 International Programs to Support Democracy, Human Rights and Labor $82,728 Yes 0
93.866 Aging Research $81,677 Yes 0
93.084 Prevention of Disease, Disability, and Death by Infectious Diseases $79,518 Yes 0
93.398 Cancer Research Manpower $78,471 Yes 0
43.001 Science $75,040 Yes 0
16.320 Services for Trafficking Victims $73,598 Yes 0
93.135 Centers for Research and Demonstration for Health Promotion and Disease Prevention $72,423 Yes 0
93.879 Medical Library Assistance $71,600 Yes 0
93.361 Covid-19 Nursing Research $68,664 Yes 0
93.398 Covid-19 Cancer Research Manpower $68,180 Yes 0
43.003 Exploration $67,428 Yes 0
93.977 Sexually Transmitted Diseases (std) Prevention and Control Grants $65,937 - 0
93.977 Covid-19 Sexually Transmitted Diseases (std) Prevention and Control Grants $65,047 - 0
93.859 Covid-19 Biomedical Research and Research Training $64,706 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $63,037 Yes 0
93.865 Child Health and Human Development Extramural Research $62,775 Yes 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $58,317 Yes 0
93.947 Tuberculosis Demonstration, Research, Public and Professional Education $57,507 Yes 0
47.074 Biological Sciences $57,369 Yes 0
93.RD Agency for Healthcare Research and Quality Contracts $55,680 Yes 0
93.242 Mental Health Research Grants $54,840 Yes 0
93.RD Consumer Product Safety Commission Contracts $54,686 Yes 0
93.686 Covid-19 Ending the Hiv Epidemic: A Plan for America — Ryan White Hiv/aids Program Parts A and B $53,792 - 0
93.RD National Aeronautics and Space Administration Contracts $53,408 Yes 0
93.RD U.s. Department of State Contracts $52,870 Yes 0
47.070 Computer and Information Science and Engineering $52,064 Yes 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $49,502 Yes 0
93.RD National Institutes of Health Contracts $49,469 Yes 0
93.394 Covid-19 Cancer Detection and Diagnosis Research $48,604 Yes 0
93.840 Covid-19 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $48,090 Yes 0
93.235 Title V State Sexual Risk Avoidance Education (title V State Srae) Program $47,523 - 0
93.399 Cancer Control $47,431 Yes 0
93.368 21st Century Cures Act - Precision Medicine Initiative $47,316 Yes 0
81.049 Office of Science Financial Assistance Program $47,085 Yes 0
93.989 International Research and Research Training $46,507 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $46,142 - 0
93.143 Niehs Superfund Hazardous Substances_basic Research and Education $43,227 Yes 0
93.U01 U.s. Department of Justice Contracts $40,386 - 0
93.RD Covid-19 Department of Defense Contracts $38,800 Yes 0
93.RD Department of Defense Contracts $37,663 Yes 0
93.978 Sexually Transmitted Diseases (std) Provider Education Grants $32,335 - 0
93.928 Special Projects of National Significance $30,090 Yes 0
93.860 Covid-19 Emerging Infections Sentinel Networks $29,394 Yes 0
93.RD Department of Veterans Affairs Contracts $28,514 Yes 0
93.361 Nursing Research $27,069 Yes 0
19.040 Public Diplomacy Programs $26,161 Yes 0
93.307 Covid-19 Minority Health and Health Disparities Research $26,044 Yes 0
47.075 Covid-19 Social, Behavioral, and Economic Sciences $23,914 Yes 0
93.732 Mental and Behavioral Health Education and Training Grants $23,240 Yes 0
12.420 Covid-19 Military Medical Research and Development $22,253 Yes 0
93.838 Lung Diseases Research $20,572 Yes 0
93.395 Cancer Treatment Research $19,720 Yes 0
93.424 Non-Aca/pphf—building Capacity of the Public Health System to Improve Population Health Through National Nonprofit Organizations $18,561 Yes 0
14.267 Continuum of Care Program $18,454 - 0
47.049 Mathematical and Physical Sciences $18,338 Yes 0
93.RD Covid-19 Biomedical Advanced Research and Development Authority $16,774 Yes 0
84.411 Education Innovation and Research (formerly Investing in Innovation (i3) Fund) $16,772 Yes 0
47.074 Covid-19 Biological Sciences $16,654 Yes 0
93.241 State Rural Hospital Flexibility Program $14,533 - 0
93.264 Nurse Faculty Loan Program (nflp) $13,656 Yes 0
93.421 Covid-19 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $13,631 Yes 0
93.359 Nurse Education, Practice Quality and Retention Grants $13,331 Yes 0
93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance $13,215 Yes 0
93.RD Covid-19 National Institutes of Health Contracts $12,971 Yes 0
93.073 Birth Defects and Developmental Disabilities - Prevention and Surveillance $11,757 - 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $11,223 Yes 0
98.012 Usaid Development Partnerships for University Cooperation and Development $10,942 - 0
93.273 Covid-19 Alcohol Research Programs $10,799 Yes 0
93.226 Covid-19 Research on Healthcare Costs, Quality and Outcomes $10,611 Yes 0
47.079 Office of International Science and Engineering $10,366 Yes 0
93.350 Covid-19 National Center for Advancing Translational Sciences $9,954 Yes 0
93.433 Acl National Institute on Disability, Independent Living, and Rehabilitation Research $8,655 Yes 0
93.RD U.s. Food & Drug Administration Contracts $6,895 Yes 0
93.129 Technical and Non-Financial Assistance to Health Centers $6,685 Yes 0
93.145 Hiv-Related Training and Technical Assistance $6,622 Yes 0
93.186 National Research Service Award in Primary Care Medicine $5,937 Yes 0
93.867 Covid-19 Vision Research $5,304 Yes 0
93.686 Ending the Hiv Epidemic: A Plan for America — Ryan White Hiv/aids Program Parts A and B $5,225 - 0
93.052 National Family Caregiver Support, Title Iii, Part E $4,000 - 0
93.RD Covid-19 U.s. Food & Drug Administration Contracts $2,695 Yes 0
93.855 Allergy and Infectious Diseases Research $2,215 Yes 0
93.866 Covid-19 Aging Research $2,201 Yes 0
93.068 Chronic Diseases: Research, Control, and Prevention $1,324 Yes 0
93.121 Covid-19 Oral Diseases and Disorders Research $1,233 Yes 0
93.069 Public Health Emergency Preparedness $1,225 - 0
93.817 Covid-19 Hospital Preparedness Program (hpp) Ebola Preparedness and Response Activities $953 - 0
93.RD U.s. Department of Justice Contracts $918 Yes 0
64.054 Research and Development $838 Yes 0
93.279 Drug Abuse and Addiction Research Programs $624 - 0
93.074 Hospital Preparedness Program (hpp) and Public Health Emergency Preparedness (phep) Aligned Cooperative Agreements $476 - 0
12.910 Covid-19 Research and Technology Development $225 Yes 0
10.561 State Administrative Matching Grants for the Supplemental Nutrition Assistance Program $20 - 0
93.943 Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (aids) and Human Immunodeficiency Virus (hiv) Infection in Selected Population Groups $5 - 0
93.286 Covid-19 Discovery and Applied Research for Technological Innovations to Improve Human Health $-22 Yes 0
21.027 Covid-19 Coronavirus State and Local Fiscal Recovery Funds $-37 - 0
47.083 Integrative Activities $-56 Yes 0
93.172 Covid-19 Human Genome Research $-160 Yes 0
93.839 Covid-19 Blood Diseases and Resources Research $-185 Yes 0
93.847 Covid-19 Diabetes, Digestive, and Kidney Diseases Extramural Research $-326 Yes 0
93.RD U.s. Department of Energy Contracts $-337 Yes 0
84.305 Education Research, Development and Dissemination $-669 Yes 0
93.889 National Bioterrorism Hospital Preparedness Program $-1,309 - 0
12.431 Basic Scientific Research $-1,824 Yes 0
10.331 Covid-19 Food Insecurity Nutrition Incentive Grants Program $-2,462 Yes 0
93.044 Special Programs for the Aging, Title Iii, Part B, Grants for Supportive Services and Senior Centers $-2,973 - 0
93.103 Food and Drug Administration Research $-3,085 Yes 0
10.331 Food Insecurity Nutrition Incentive Grants Program $-3,106 Yes 0
93.113 Environmental Health $-4,545 Yes 0
21.019 Covid-19 Coronavirus Relief Fund $-7,270 - 0
93.RD Centers for Diseases Control and Prevention Contracts $-7,886 Yes 0
12.750 Uniformed Services University Medical Research Projects $-8,579 Yes 0
16.575 Crime Victim Assistance $-11,658 - 0
16.582 Crime Victim Assistance/discretionary Grants $-12,900 - 0
93.986 Medicare Access and Chip Reauthorization Act (macra) Funding Opportunity: Measure Development for the Quality Payment Program $-19,750 Yes 0
93.837 Cardiovascular Diseases Research $-20,025 Yes 0
93.067 Global Aids $-20,043 Yes 0
93.825 Covid-19 National Ebola Training and Education Center (netec) $-21,796 Yes 0

Contacts

Name Title Type
YS8MKJGJN857 Rhonda Lowe Auditee
8572820711 Karen Pfeil Auditor
No contacts on file

Notes to SEFA

Title: Organization Accounting Policies: Mass General Brigham Incorporated (the Company) is the parent organization and sole corporate member of numerous organizations whose financial condition and operations are described in the consolidated financial statements. The terms Mass General Brigham, We, Our or Us as used herein, unless otherwise stated or indicated by context, refer collectively to the Company and its affiliated organizations. Mass General Brigham operates academic medical centers, community acute care hospitals, inpatient and outpatient mental health services facilities, urgent care centers, facilities that provide rehabilitation medicine and long-term care services, physician organizations, home health services, nursing homes and a graduate level program for health professions. Our mission is to provide world class health care services to the local communities in which we operate as well as to patients across the United States and the world. In addition, we are a nonuniversity-based nonprofit private medical research enterprise and a principal teaching affiliate of the medical and dental schools of Harvard University. Our licensed, not-for-profit managed care organization (Mass General Brigham Health Plan, Inc.) and licensed, for-profit insurance company (Mass General Brigham Health Plan) (collectively referred to as Mass General Brigham Health Plan) provide health insurance products and administrative services to the Massachusetts Medicaid program (MassHealth), ConnectorCare (a state subsidized program for adults who meet income and immigration guidelines) and commercial populations. Summary of Significant Accounting Policies Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal award activity of Mass General Brigham and is recorded on the accrual basis of accounting. The information in the Schedule is presented in accordance with Title 2 U.S. Code of Federal Regulations (CFR) 200 Uniform Administrative Requirements Cost Principles and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic consolidated financial statements. Negative amounts represent adjustments to amounts reported as expenditures in prior years in the normal course of business. Assistance Listing Number (ALN) and pass-through award numbers are provided where available. The Schedule combines expenditures of The Brigham and Women’s Hospital, Inc., The General Hospital Corporation d/b/a The Massachusetts General Hospital (MGH), Massachusetts Eye and Ear Infirmary, including Schepens Eye Research Institute, Inc., The McLean Hospital Corporation, The MGH Institute of Health Professions, Inc., The Spaulding Rehabilitation Hospital Corporation, including Spaulding Hospital-Cambridge, Inc. and Spaulding Nursing and Therapy Center Brighton, Inc., Cooley Dickinson Hospital, Inc., North Shore Medical Center, Inc. d/b/a Salem Hospital, Newton-Wellesley Hospital, Brigham and Women’s Faulkner Hospital, Inc., Martha’s Vineyard Hospital, Inc., Nantucket Cottage Hospital, Mass General Brigham Community Physicians, Inc., Wentworth-Douglass Hospital, and Mass General Brigham. These entities are all affiliates of Mass General Brigham. Federal expenditures for Research and Development and Research and Development Training for Brigham and Women’s Hospital, Massachusetts General Hospital, McLean, Massachusetts Eye and Ear Infirmary, Schepens Eye Research Institute, Spaulding Rehabilitation Hospital and the MGH Institute of Health Professions include facilities and administrative cost recoveries and fringe benefit cost recoveries in the amounts reported in the Schedule based on rates negotiated and awarded with the DHHS Division of Cost Allocation. These rates are based on financial information submitted utilizing the methods prescribed in Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, contained in the Code of Federal Regulation, Title 45, Part 74, Appendix E (OASC-3). The predetermined facilities and administrative cost rates for IHP are based on financial information submitted utilizing the simplified method for small institutions prescribed in Indirect (F&A) Costs Identification and Assignment, and Rate Determination for Institutions of Higher Education (IHEs), contained in the Code of Federal Regulation, Title 2, Part 200, Appendix III. Expenditures reported in Training and Other include the maximum facilities and administrative recoveries approved by the sponsor. The 10% de-minimis rate is not utilized on Research and Development or Research and Development Training by Mass General Brigham because they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other awards where allowed. De Minimis Rate Used: Both Rate Explanation: The 10% de-minimis rate is not utilized on Research and Development or Research and Development Training by Mass General Brigham because they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other awards where allowed. Mass General Brigham Incorporated (the Company) is the parent organization and sole corporate member of numerous organizations whose financial condition and operations are described in the consolidated financial statements. The terms Mass General Brigham, We, Our or Us as used herein, unless otherwise stated or indicated by context, refer collectively to the Company and its affiliated organizations. Mass General Brigham operates academic medical centers, community acute care hospitals, inpatient and outpatient mental health services facilities, urgent care centers, facilities that provide rehabilitation medicine and long-term care services, physician organizations, home health services, nursing homes and a graduate level program for health professions. Our mission is to provide world class health care services to the local communities in which we operate as well as to patients across the United States and the world. In addition, we are a nonuniversity-based nonprofit private medical research enterprise and a principal teaching affiliate of the medical and dental schools of Harvard University. Our licensed, not-for-profit managed care organization (Mass General Brigham Health Plan, Inc.) and licensed, for-profit insurance company (Mass General Brigham Health Plan) (collectively referred to as Mass General Brigham Health Plan) provide health insurance products and administrative services to the Massachusetts Medicaid program (MassHealth), ConnectorCare (a state subsidized program for adults who meet income and immigration guidelines) and commercial populations. Summary of Significant Accounting Policies Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal award activity of Mass General Brigham and is recorded on the accrual basis of accounting. The information in the Schedule is presented in accordance with Title 2 U.S. Code of Federal Regulations (CFR) 200 Uniform Administrative Requirements Cost Principles and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic consolidated financial statements. Negative amounts represent adjustments to amounts reported as expenditures in prior years in the normal course of business. Assistance Listing Number (ALN) and pass-through award numbers are provided where available. The Schedule combines expenditures of The Brigham and Women’s Hospital, Inc., The General Hospital Corporation d/b/a The Massachusetts General Hospital (MGH), Massachusetts Eye and Ear Infirmary, including Schepens Eye Research Institute, Inc., The McLean Hospital Corporation, The MGH Institute of Health Professions, Inc., The Spaulding Rehabilitation Hospital Corporation, including Spaulding Hospital-Cambridge, Inc. and Spaulding Nursing and Therapy Center Brighton, Inc., Cooley Dickinson Hospital, Inc., North Shore Medical Center, Inc. d/b/a Salem Hospital, Newton-Wellesley Hospital, Brigham and Women’s Faulkner Hospital, Inc., Martha’s Vineyard Hospital, Inc., Nantucket Cottage Hospital, Mass General Brigham Community Physicians, Inc., Wentworth-Douglass Hospital, and Mass General Brigham. These entities are all affiliates of Mass General Brigham. Federal expenditures for Research and Development and Research and Development Training for Brigham and Women’s Hospital, Massachusetts General Hospital, McLean, Massachusetts Eye and Ear Infirmary, Schepens Eye Research Institute, Spaulding Rehabilitation Hospital and the MGH Institute of Health Professions include facilities and administrative cost recoveries and fringe benefit cost recoveries in the amounts reported in the Schedule based on rates negotiated and awarded with the DHHS Division of Cost Allocation. These rates are based on financial information submitted utilizing the methods prescribed in Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, contained in the Code of Federal Regulation, Title 45, Part 74, Appendix E (OASC-3). The predetermined facilities and administrative cost rates for IHP are based on financial information submitted utilizing the simplified method for small institutions prescribed in Indirect (F&A) Costs Identification and Assignment, and Rate Determination for Institutions of Higher Education (IHEs), contained in the Code of Federal Regulation, Title 2, Part 200, Appendix III. Expenditures reported in Training and Other include the maximum facilities and administrative recoveries approved by the sponsor. The 10% de-minimis rate is not utilized on Research and Development or Research and Development Training by Mass General Brigham because they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other awards where allowed.
Title: Federal Student Loan Programs Accounting Policies: Mass General Brigham Incorporated (the Company) is the parent organization and sole corporate member of numerous organizations whose financial condition and operations are described in the consolidated financial statements. The terms Mass General Brigham, We, Our or Us as used herein, unless otherwise stated or indicated by context, refer collectively to the Company and its affiliated organizations. Mass General Brigham operates academic medical centers, community acute care hospitals, inpatient and outpatient mental health services facilities, urgent care centers, facilities that provide rehabilitation medicine and long-term care services, physician organizations, home health services, nursing homes and a graduate level program for health professions. Our mission is to provide world class health care services to the local communities in which we operate as well as to patients across the United States and the world. In addition, we are a nonuniversity-based nonprofit private medical research enterprise and a principal teaching affiliate of the medical and dental schools of Harvard University. Our licensed, not-for-profit managed care organization (Mass General Brigham Health Plan, Inc.) and licensed, for-profit insurance company (Mass General Brigham Health Plan) (collectively referred to as Mass General Brigham Health Plan) provide health insurance products and administrative services to the Massachusetts Medicaid program (MassHealth), ConnectorCare (a state subsidized program for adults who meet income and immigration guidelines) and commercial populations. Summary of Significant Accounting Policies Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal award activity of Mass General Brigham and is recorded on the accrual basis of accounting. The information in the Schedule is presented in accordance with Title 2 U.S. Code of Federal Regulations (CFR) 200 Uniform Administrative Requirements Cost Principles and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic consolidated financial statements. Negative amounts represent adjustments to amounts reported as expenditures in prior years in the normal course of business. Assistance Listing Number (ALN) and pass-through award numbers are provided where available. The Schedule combines expenditures of The Brigham and Women’s Hospital, Inc., The General Hospital Corporation d/b/a The Massachusetts General Hospital (MGH), Massachusetts Eye and Ear Infirmary, including Schepens Eye Research Institute, Inc., The McLean Hospital Corporation, The MGH Institute of Health Professions, Inc., The Spaulding Rehabilitation Hospital Corporation, including Spaulding Hospital-Cambridge, Inc. and Spaulding Nursing and Therapy Center Brighton, Inc., Cooley Dickinson Hospital, Inc., North Shore Medical Center, Inc. d/b/a Salem Hospital, Newton-Wellesley Hospital, Brigham and Women’s Faulkner Hospital, Inc., Martha’s Vineyard Hospital, Inc., Nantucket Cottage Hospital, Mass General Brigham Community Physicians, Inc., Wentworth-Douglass Hospital, and Mass General Brigham. These entities are all affiliates of Mass General Brigham. Federal expenditures for Research and Development and Research and Development Training for Brigham and Women’s Hospital, Massachusetts General Hospital, McLean, Massachusetts Eye and Ear Infirmary, Schepens Eye Research Institute, Spaulding Rehabilitation Hospital and the MGH Institute of Health Professions include facilities and administrative cost recoveries and fringe benefit cost recoveries in the amounts reported in the Schedule based on rates negotiated and awarded with the DHHS Division of Cost Allocation. These rates are based on financial information submitted utilizing the methods prescribed in Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, contained in the Code of Federal Regulation, Title 45, Part 74, Appendix E (OASC-3). The predetermined facilities and administrative cost rates for IHP are based on financial information submitted utilizing the simplified method for small institutions prescribed in Indirect (F&A) Costs Identification and Assignment, and Rate Determination for Institutions of Higher Education (IHEs), contained in the Code of Federal Regulation, Title 2, Part 200, Appendix III. Expenditures reported in Training and Other include the maximum facilities and administrative recoveries approved by the sponsor. The 10% de-minimis rate is not utilized on Research and Development or Research and Development Training by Mass General Brigham because they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other awards where allowed. De Minimis Rate Used: Both Rate Explanation: The 10% de-minimis rate is not utilized on Research and Development or Research and Development Training by Mass General Brigham because they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other awards where allowed. The amounts reported in the Student Financial Aid Cluster of the Schedule represent the beginning balances and newly issued loans in fiscal year 2023. As of September 30, 2023, the MGH Institute of Health Professions (IHP) had loans outstanding of $119,940 for loans issued as part of the Nurse Faculty Loan Program (ALN 93.264). IHP had Direct Loans issued by the Department of Education of $39,966,646 as of September 30, 2023 for ALN 84.268.
Title: Federal Emergency Management Agency (FEMA) Public Assistance Accounting Policies: Mass General Brigham Incorporated (the Company) is the parent organization and sole corporate member of numerous organizations whose financial condition and operations are described in the consolidated financial statements. The terms Mass General Brigham, We, Our or Us as used herein, unless otherwise stated or indicated by context, refer collectively to the Company and its affiliated organizations. Mass General Brigham operates academic medical centers, community acute care hospitals, inpatient and outpatient mental health services facilities, urgent care centers, facilities that provide rehabilitation medicine and long-term care services, physician organizations, home health services, nursing homes and a graduate level program for health professions. Our mission is to provide world class health care services to the local communities in which we operate as well as to patients across the United States and the world. In addition, we are a nonuniversity-based nonprofit private medical research enterprise and a principal teaching affiliate of the medical and dental schools of Harvard University. Our licensed, not-for-profit managed care organization (Mass General Brigham Health Plan, Inc.) and licensed, for-profit insurance company (Mass General Brigham Health Plan) (collectively referred to as Mass General Brigham Health Plan) provide health insurance products and administrative services to the Massachusetts Medicaid program (MassHealth), ConnectorCare (a state subsidized program for adults who meet income and immigration guidelines) and commercial populations. Summary of Significant Accounting Policies Basis of Presentation The accompanying Schedule of Expenditures of Federal Awards (the Schedule) includes the Federal award activity of Mass General Brigham and is recorded on the accrual basis of accounting. The information in the Schedule is presented in accordance with Title 2 U.S. Code of Federal Regulations (CFR) 200 Uniform Administrative Requirements Cost Principles and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in the Schedule may differ from amounts presented in or used in the preparation of the basic consolidated financial statements. Negative amounts represent adjustments to amounts reported as expenditures in prior years in the normal course of business. Assistance Listing Number (ALN) and pass-through award numbers are provided where available. The Schedule combines expenditures of The Brigham and Women’s Hospital, Inc., The General Hospital Corporation d/b/a The Massachusetts General Hospital (MGH), Massachusetts Eye and Ear Infirmary, including Schepens Eye Research Institute, Inc., The McLean Hospital Corporation, The MGH Institute of Health Professions, Inc., The Spaulding Rehabilitation Hospital Corporation, including Spaulding Hospital-Cambridge, Inc. and Spaulding Nursing and Therapy Center Brighton, Inc., Cooley Dickinson Hospital, Inc., North Shore Medical Center, Inc. d/b/a Salem Hospital, Newton-Wellesley Hospital, Brigham and Women’s Faulkner Hospital, Inc., Martha’s Vineyard Hospital, Inc., Nantucket Cottage Hospital, Mass General Brigham Community Physicians, Inc., Wentworth-Douglass Hospital, and Mass General Brigham. These entities are all affiliates of Mass General Brigham. Federal expenditures for Research and Development and Research and Development Training for Brigham and Women’s Hospital, Massachusetts General Hospital, McLean, Massachusetts Eye and Ear Infirmary, Schepens Eye Research Institute, Spaulding Rehabilitation Hospital and the MGH Institute of Health Professions include facilities and administrative cost recoveries and fringe benefit cost recoveries in the amounts reported in the Schedule based on rates negotiated and awarded with the DHHS Division of Cost Allocation. These rates are based on financial information submitted utilizing the methods prescribed in Principles for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, contained in the Code of Federal Regulation, Title 45, Part 74, Appendix E (OASC-3). The predetermined facilities and administrative cost rates for IHP are based on financial information submitted utilizing the simplified method for small institutions prescribed in Indirect (F&A) Costs Identification and Assignment, and Rate Determination for Institutions of Higher Education (IHEs), contained in the Code of Federal Regulation, Title 2, Part 200, Appendix III. Expenditures reported in Training and Other include the maximum facilities and administrative recoveries approved by the sponsor. The 10% de-minimis rate is not utilized on Research and Development or Research and Development Training by Mass General Brigham because they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other awards where allowed. De Minimis Rate Used: Both Rate Explanation: The 10% de-minimis rate is not utilized on Research and Development or Research and Development Training by Mass General Brigham because they have approved negotiated rate agreements. The 10% de-minimis rate is used for Other awards where allowed. Mass General Brigham applied for reimbursement of certain expenses related to the COVID-19 pandemic under Assistance Listing #97.036, FEMA Public Assistance through the Commonwealth of Massachusetts. Expenditures are reflected in the Schedule of Federal Expenditures (SEFA) in the year in which a project application is obligated. The Schedule thus includes $134,464,310 of expenditures incurred in fiscal years 2020, 2021 and 2022, which were obligated in fiscal year 2023 and represents a reconciling item between the federal expenses in Mass General Brigham’s financial statements and the amount included on the Schedule.